Search

everythinglearnresearchcommunity

for

Search:↓

FPHL affects hair density and diameter, causing visible hair loss in older women.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Hair regrowth doesn't convert thin hairs to thick hairs, but increases overall hair density.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

French maritime pine bark extract significantly increased hair density in menopausal women.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Injections improve hair growth, density, and thickness in women safely.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Both methods improve hair density and thickness; double-spin may be more effective.

Combination therapy works best for female hair loss, increasing density and thickness.

Digital imaging can effectively evaluate the donor area for hair transplants, showing variations in hair density and grouping by age and severity of hair loss.

Low iron levels may be linked to hair loss in women with chronic telogen effluvium.

Using 448-kHz Capacitive-Resistive Electrothermal Therapy can help increase hair density and prevent hair loss in women.